Skip to main content

Day: May 1, 2025

HeartSciences Announces Launch of MyoVista Insights™ Platform and Related Early Adopter Program

Southlake, TX, May 01, 2025 (GLOBE NEWSWIRE) — HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company“), an artificial intelligence (“AI”)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced today that it has launched the MyoVista InsightsTM platform and related early adopter program for select reference sites. MyoVista Insights is a cloud-native next-generation ECG Management System designed to enhance both clinical decision-making and healthcare IT efficiency. It will integrate company developed and third-party AI-ECG algorithms as part of future releases and the current platform offers a robust set of features that streamline ECG workflows and reduce costs for healthcare providers. “I like...

Continue reading

AirTera℠ Acquires Safety and Security Instruction (SSi), Creating Aviation’s First Unified Platform for Identity, Safety, Security, and Dynamic Training

PHOENIX, May 01, 2025 (GLOBE NEWSWIRE) — Today, AirTera℠, the service mark of NATA Compliance Services (NATA CS), announced the acquisition of Safety and Security Instruction (SSi), a premier provider of learning management systems (LMS) and airport-specific training content for the aviation industry. This move positions AirTera℠ as the most comprehensive, real-time platform for security, identity management, safety oversight, and automated training in the aviation ecosystem. Through this strategic acquisition, AirTera℠ now unites the capabilities of NATA CS, Soar SMS, and SSi, delivering an unmatched platform that empowers airports, air operators, and ground facilities to streamline credentialing, compliance, and training—while increasing cybersecurity, reducing liability, and dramatically improving operational efficiency. “With...

Continue reading

Resmed Acquires VirtuOx

Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions. The acquisition reflects Resmed’s commitment to improving the way care is delivered—by making it more accessible, more coordinated, and more patient friendly. With VirtuOx’s at-home diagnostic services, Resmed will be better positioned to support patients earlier in their journey and help healthcare providers and homecare companies deliver care in a simpler, more connected...

Continue reading

Formidium Acquires Assets of Praxonomy Ltd, Strengthening Corporate Services Offering

CHICAGO, May 01, 2025 (GLOBE NEWSWIRE) — Formidium UK Ltd., a wholly owned subsidiary of Formidium Corp., a global leader in fund administration solutions and technology, has successfully acquired assets of Praxonomy Ltd. This strategic acquisition aims to strengthen Formidium’s corporate services portfolio by integrating Praxonomy’s flagship cloud-based board management solution, Boardlogic. Praxonomy, a UK-based software company, specialized in optimizing board governance through secure, intuitive, and efficient technology. Its primary product, Boardlogic, is a purpose-built collaboration platform designed exclusively for boards of directors. The platform facilitates seamless meeting management, secure document sharing, real-time communication, and informed decision-making, all within a highly secure and cost-effective environment....

Continue reading

California Water Service Group Reports First Quarter 2025 Results

SAN JOSE, Calif., May 01, 2025 (GLOBE NEWSWIRE) — California Water Service Group (“Group” or “Company,” NYSE: CWT), a leading publicly traded water utility serving California, Hawaii, New Mexico, Washington, and Texas, today reported financial results for the first quarter 2025. Financial highlights included:The inclusion of both GAAP and non-GAAP financial measures for 2024 to assist investors in comparing 2024 and 2025 performance.Net income attributable to Group of $13.3 million, or $0.22 per diluted share, a decrease of $56.6 million and $0.99 per share, respectively, compared to the same period in the prior year. However, Q1 2025 net income and diluted earnings per share increased by $9.2 million and $0.15, respectively, compared to Q1 2024 non-GAAP net income of $4.1 million and diluted earnings per share of $0.07.Operating...

Continue reading

West Completes Sale of Notified to Equiniti

ISLANDIA, N.Y., May 01, 2025 (GLOBE NEWSWIRE) — West Technology Group, LLC (the “Company” or “West”) has completed the sale of its Notified business to Equiniti (EQ)1, a global leader in shareholder services and advisory firm. “We are pleased to complete the sale of Notified and believe that the complementary strengths of EQ and Notified will elevate the platform to new heights,” said John Shlonsky, President and Chief Executive Officer of West. “Notified has transformed the way businesses connect with stakeholders, and we are confident that under EQ’s leadership, it will continue to innovate and expand its reach. We look forward to seeing Notified flourish in its next chapter.” The sale price was $534.5 million, inclusive of an $80 million earnout. The Company intends to use the net proceeds of the sale in accordance with its...

Continue reading

Equiniti (EQ) Completes Acquisition of Notified, Creating a Global Leader in End-to-End Shareholder and Corporate Communications 

Combining EQ’s shareholder services and robust Investor Relations (IR) capabilities with Notified’s public relations (PR) and IR solutions to help companies grow, engage stakeholders and communicate with confidence at every stage.   Transaction Highlights Establishes Comprehensive Solution: Combines EQ’s shareholder services leadership and robust IR capabilities with Notified’s PR and IR expertise to deliver a comprehensive solution for companies at every stage of growth.  Supports the Full Corporate Lifecycle: Equips public and private companies with tools for shareholder engagement, disclosure and media outreach from pre-IPO through maturity.  Extends Global Reach and Client Base: Serves 12,000 clients in 90 countries including more than half of the FTSE 100, one third of the S&P 500 and half of the Nasdaq.   Accelerates Innovation...

Continue reading

Extendicare Announces Agreement to Acquire Closing the Gap Healthcare Group

MARKHAM, Ontario, May 01, 2025 (GLOBE NEWSWIRE) — Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that its wholly owned home health care subsidiary, ParaMed Inc. (“ParaMed” or the “Purchaser”), has entered into an agreement to acquire all of the issued and outstanding shares of Closing the Gap Healthcare Group Inc. and certain affiliates (collectively, “Closing the Gap”) from the ultimate shareholders of Closing the Gap (the “Transaction”). Closing of the Transaction is subject to customary closing conditions, including receipt of consents from third parties, including the Minister of Health for Ontario and the Minister of Seniors and Long-Term Care for Nova Scotia, and is not conditional on financing or due diligence. The Transaction is anticipated to close in the third quarter of 2025. ParaMed is...

Continue reading

Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) — Kronos Bio, Inc. (“Kronos Bio”) (Nasdaq: KRON), a biotechnology company that has been developing small molecule therapeutics to address cancers and other diseases driven by deregulated transcription, today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) with Concentra Biosciences, LLC ( “Concentra”), whereby Concentra will acquire Kronos Bio for $0.57 in cash per share of Kronos Bio common stock (“Kronos Bio Common Stock”), plus one non-tradeable contingent value right (“CVR”), which represents the right to receive: (i) 50% of the net proceeds in the case of a disposition of the Company’s product candidates known as KB-9558 and KB-7898 that occurs within 2 years following closing; (ii) 100% of the net proceeds in...

Continue reading

Itron Announces First Quarter 2025 Financial Results

LIBERTY LAKE, Wash., May 01, 2025 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating the way utilities and cities manage energy and water, announced today financial results for its first quarter ended March 31, 2025. Key results for the quarter include (compared with the first quarter of 2024):Revenue of $607 million, increased 1%; Gross profit of $217 million, increased 6%; GAAP net income attributable to Itron, Inc. of $65 million, increased $14 million; GAAP diluted earnings per share of $1.42, increased $0.30 per share; Non-GAAP diluted EPS of $1.52, increased $0.28 per share; Adjusted EBITDA of $88 million, increased 15%; and Free cash flow of $67 million, increased $33 million.“First quarter margin expansion and earnings growth were ahead of expectations due to favorable product mix and continued...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.